my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
BioCurex Inc. is a biotechnology company that is developing products based on patented/proprietary technology for cancer diagnosis and therapy. The core technology identifies a cancer marker known as RECAF, found only on malignant cells in a variety of cancers, but absent in normal and most benign cells. Biocurex is also working on further methods for cancer detection and cancer treatment.
BioCurex Inc. announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries. The subject of this patent is a synthetic peptide that recognizes RECAF™ and that can replace the antibodies used in BioCurex's RECAF test. The synthetic pe ... > more
BioCurex Inc. announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healt ... > more
BioCurex Inc. as incorporated a fully-owned subsidiary, BioCurex China, in Shanghai. This followed a lengthy legal process - required of all foreign companies - that took several months to complete. The subsidiary will initially operate as a clinical laboratory for RECAF testing and will s ... > more
BioCurex Inc. announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries. The subject of this patent is a synthetic peptide that recognizes RECAF™ and that can replace the antibodies used in BioCurex's RECAF test. The synthetic pe ... more
BioCurex Announces Positive First Results for Monitoring Cancer Therapy Using its RECAF Blood Test
BioCurex Inc. announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healt ... more
BioCurex Incorporates Chinese Subsidiary
BioCurex Inc. as incorporated a fully-owned subsidiary, BioCurex China, in Shanghai. This followed a lengthy legal process - required of all foreign companies - that took several months to complete. The subsidiary will initially operate as a clinical laboratory for RECAF testing and will s ... more
© 1997-2019 LUMITOS AG, All rights reserved
